Kazuhiro Tomizawa

776 total citations
18 papers, 586 citations indexed

About

Kazuhiro Tomizawa is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Kazuhiro Tomizawa has authored 18 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Kazuhiro Tomizawa's work include Immunodeficiency and Autoimmune Disorders (4 papers), Viral-associated cancers and disorders (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Kazuhiro Tomizawa is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (4 papers), Viral-associated cancers and disorders (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Kazuhiro Tomizawa collaborates with scholars based in Japan. Kazuhiro Tomizawa's co-authors include Yukio Sakiyama, Shuzo Matsumoto, Yuichi Taguchi, Katsura Kojima, Akitoshi Ishizaka, Kimikazu Kojima, Akihito Ishizaka, Hídeaki Kikuta, N. Kawamura and Kanji Hirai and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Kazuhiro Tomizawa

18 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuhiro Tomizawa Japan 11 228 204 105 102 101 18 586
Marta Siviero Italy 14 411 1.8× 226 1.1× 50 0.5× 121 1.2× 95 0.9× 16 779
Soji YAMAZAKI Japan 14 105 0.5× 84 0.4× 47 0.4× 150 1.5× 173 1.7× 69 658
F Ersoy Türkiye 14 277 1.2× 148 0.7× 68 0.6× 118 1.2× 83 0.8× 43 582
Renata Mazzucchelli Italy 11 774 3.4× 249 1.2× 87 0.8× 91 0.9× 72 0.7× 13 1.1k
MG Roncarolo France 13 849 3.7× 176 0.9× 51 0.5× 91 0.9× 67 0.7× 20 1.2k
Satoshi Ikushima Japan 14 307 1.3× 145 0.7× 262 2.5× 41 0.4× 67 0.7× 24 775
Sergio Sánchez-Sosa Mexico 11 93 0.4× 134 0.7× 47 0.4× 55 0.5× 94 0.9× 22 422
Atsuko Masunaga Japan 13 156 0.7× 173 0.8× 48 0.5× 83 0.8× 43 0.4× 51 557
K. Aroni Greece 12 65 0.3× 104 0.5× 53 0.5× 111 1.1× 71 0.7× 45 560
Schwartz Rs United States 12 321 1.4× 127 0.6× 25 0.2× 102 1.0× 122 1.2× 27 835

Countries citing papers authored by Kazuhiro Tomizawa

Since Specialization
Citations

This map shows the geographic impact of Kazuhiro Tomizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiro Tomizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiro Tomizawa more than expected).

Fields of papers citing papers by Kazuhiro Tomizawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhiro Tomizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiro Tomizawa. The network helps show where Kazuhiro Tomizawa may publish in the future.

Co-authorship network of co-authors of Kazuhiro Tomizawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiro Tomizawa. A scholar is included among the top collaborators of Kazuhiro Tomizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiro Tomizawa. Kazuhiro Tomizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Morikawa, Shuntaro, Akie Nakamura, Kumihiro Matsuo, et al.. (2018). Four Japanese Patients with Congenital Nephrogenic Diabetes Insipidus due to the AVPR2 Mutations. SHILAP Revista de lepidopterología. 2018(1). 6561952–6561952. 8 indexed citations
2.
Tsurusaki, Yoshinori, Shinji Saitoh, Kazuhiro Tomizawa, et al.. (2012). A DYNC1H1 mutation causes a dominant spinal muscular atrophy with lower extremity predominance. Neurogenetics. 13(4). 327–332. 49 indexed citations
3.
Nakanishi, Masanori, Hídeaki Kikuta, Kazuhiro Tomizawa, et al.. (1993). Distinct clonotypic Epstein–Barr virus-induced fatal lymphoproliferative disorder in a patient with wiskott-aldrich syndrome. Cancer. 72(4). 1376–1381. 22 indexed citations
4.
Ariga, Tadashi, Yukio Sakiyama, Kazuhiro Tomizawa, et al.. (1993). A newly recognized point mutation in the cytochrome b558 heavy chain gene replacing alanine57 by glutamic acid, in a patient with cytochrome b positive X-linked chronic granulomatous disease. European Journal of Pediatrics. 152(6). 469–472. 20 indexed citations
5.
Satake, Naoya, Masako Nakanishi, Motohiko Okano, et al.. (1993). A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathy. European Journal of Pediatrics. 152(4). 313–315. 58 indexed citations
6.
Ariga, Tadashi, Masanori Nakanishi, Kazuhiro Tomizawa, et al.. (1992). Genetic Heterogeneity in Patients with X-Linked Recessive Chronic Granulomatous Disease. Pediatric Research. 31(5). 516–519. 10 indexed citations
7.
Tomizawa, Kazuhiro, Akitoshi Ishizaka, Masahiro Nakanishi, et al.. (1992). Interleukin-4 down-regulates the IL2Rp70-75 expressed on human natural killer cells. Immunology Letters. 32(2). 101–103. 1 indexed citations
8.
Azuma, Hiroshi, Kazuhiro Sasaki, Yasuhiro Makita, et al.. (1992). Cytochrome b positive X-linked chronic granulomatous disease: A normal cell surface expression of cytochrome b. European Journal of Pediatrics. 151(4). 279–282. 4 indexed citations
9.
Togashi, Takehiro, et al.. (1991). Steroid Therapy for Bronchopneumonia in Chronic Granulomatous Disease. Pediatrics International. 33(2). 181–185. 13 indexed citations
10.
Tomizawa, Kazuhiro, Akitoshi Ishizaka, Katsura Kojima, et al.. (1991). Interleukin-4 regulates the interleukin-2 receptors on human peripheral blood B lymphocytes. Clinical & Experimental Immunology. 83(3). 492–496. 11 indexed citations
11.
Kojima, Kimikazu, Akihito Ishizaka, Yuichi Taguchi, et al.. (1990). Quantitation of IgG subclass antibodies to pneumococcal capsular polysaccharides by ELISA, using pneumovax-specific antibodies as a reference.. The Tohoku Journal of Experimental Medicine. 161(3). 209–215. 15 indexed citations
12.
Kikuta, H., et al.. (1990). Enhancement of Human Herpesvirus 6 Replication in Adult Human Lymphocytes by Monoclonal Antibody to CD3. The Journal of Infectious Diseases. 161(6). 1085–1087. 15 indexed citations
13.
Ishizaka, Akitoshi, Yukio Sakiyama, Masayoshi Nakanishi, et al.. (1990). The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes. Clinical & Experimental Immunology. 79(3). 392–396. 106 indexed citations
14.
Ishizaka, Akitoshi, Kensuke Joh, Rumiko Shibata, et al.. (1990). Regulation of IgE and IgG4 synthesis in patients with hyper IgE syndrome.. PubMed. 70(3). 414–6. 22 indexed citations
15.
Kobayashi, Ichiro, Isamu Hamada, Kazuhiro Tomizawa, et al.. (1989). Chronic Epstein‐Barr Virus Infections Associated with Coronary Aneurysms. Pediatrics International. 31(4). 509–512. 2 indexed citations
16.
Kato, Naoko, et al.. (1989). [An adult case of mixed connective tissue disease associated with myocardial infarction].. PubMed. 99(1). 59–66. 1 indexed citations
17.
Kikuta, Hídeaki, Yuichi Taguchi, Kazuhiro Tomizawa, et al.. (1988). Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature. 333(6172). 455–457. 226 indexed citations
18.
Tomizawa, Kazuhiro & Showbu Sato. (1988). [An analysis of incidents of Staphylococcus in Kashima Rosai Hospital (I)].. PubMed. 41(5). 494–504. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026